Proton therapy treatment monitoring with in-beam PET: Investigating space and time activity distributions by Brombal, Luca et al.
1Contents lists available at ScienceDirect
Nuclear Instruments and Methods in Physics Research A
journal homepage: www.elsevier.com/locate/nima
Proton therapy treatment monitoring with in-beam PET: Investigating
space and time activity distributions
L. Brombala,b,⁎, D. Barbosac,d, N. Belcaric,d, M.G. Bisognic,d, N. Camarlinghic,d, L. Cristoforettie,
A. Del Guerrac,d, F. Fracchiollae, M. Morrocchic,d, G. Sportellic,d, R. Righettoe, M. Schwarze,f,
A. Topig,d, V. Rossoc,d
a Department of Physics, University of Trieste, Trieste, Italy
b INFN- sezione di Trieste
c Department of Physics, University of Pisa, Pisa, Italy
d INFN- sezione di Pisa
e Proton Therapy Department, Trento Hospital, Trento, Italy
f TIFPA INFN, Trento, Italy
g Department of Physical Sciences, Earth and Environment, University of Siena, Siena, Italy





A B S T R A C T
In this study the possibility of retrieving composition information in proton therapy with a planar in-beam PET
scanner is investigated. The analysis focuses both on spatial activity distributions and time dependence of the
recorded signal. The experimental data taking was performed at the Trento Proton Therapy Center (IT) by
irradiating three diﬀerent phantoms. We show that diﬀerent phantom compositions reﬂect into diﬀerent activity
proﬁle shapes. We demonstrate that the analysis of the event rate can provide signiﬁcant information on the
phantom elemental composition, suggesting that elemental analysis could be used along with activity proﬁle
analysis to achieve a more accurate treatment monitoring.
1. Introduction
Radiotherapy is one of the key players in modern cancer treatment
and roughly 45–55% of cancer patients require radiotherapy at some
point [1]. The goal of the treatment is to deliver a high conformal dose
to the tumor region, minimizing the dose to the surrounding tissues.
Proton therapy is a leading edge radiotherapy technique which
allows the delivery of high-dose in well-deﬁned volumes (Bragg-peak)
signiﬁcantly reducing the absorbed dose in the sorroundings. However,
due to the steep dose proﬁle of protons, this technique is much more
sensitive to spatial uncertainties than conventional photon treatments.
In fact, uncertainties in particle range, unexpected anatomical changes
and patient or accelerator setup errors, may cause either severe over-
or under-dosage in the target or increased dose in adjacent tissues
[2,3]. For this reason, a system which allows to monitor the treatment
would be highly desirable. Since protons stop in the patient, in-vivo
treatment monitoring requires detecting secondary radiation.
So far, Positron Emission Tomography (PET) is the most studied
monitoring technique [4–9]. It is based on the detection of back-to-
back photons (511 keV) originating from e- e+ annihilation: in proto-
ntherapy the positron arises from β+ emitters (mainly 11C and 15O)
generated by nuclear interaction between protons and the patient
tissues. Actually, nuclear interactions at clinically used energies
produce also other secondary particle as prompt gamma rays and
charged particle which can be used for monitoring purposes: recently
the ﬁrst clinical application of a prompt gamma based monitoring
system has been performed [10], while systems using charged particles
are under investigation [11–13]. A detailed review about nuclear
interactions in particle therapy can be found in [14]. For PET the
recorded signal, i.e., the isotopic activity, is only indirectly related to
the delivered dose, although a useful information on the proton range
can be inferred [15–17]. Furthermore, since the recorded signal and
the tissue composition are directly related, the analysis of activity
proﬁles and signal time dependence can provide extra-information on
the elemental composition of the irradiated object. The latter kind of
analysis, in which the detected coincidence rate as a function of time is
studied, will hereinafter referred to as elemental analysis.
In this study a large area dual head PET prototype developed and
built in Pisa is used. The system is an upgraded version of DoPET
prototype [18] with an active area of about 15×15 cm2 which allows to
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2cope with volumes encountered in the clinical practice. Irradiations
were performed at the cyclotron of Trento Proton Therapy Center using
plastic phantoms.
The aim of this work is to investigate the DoPET capability of
providing information on the irradiated phantom compositions both in
space and in time domains.
2. Materials and methods
2.1. PET system
The present system is based on an upgraded version of DoPET
prototype where new ten modules were built and added to the previous
eight modules detector. Each head covers an area of about 15×15 cm2
and it is composed by 9 independent modules. Each module consists of
a 23×23 LYSO crystal matrix (∼2 mm pitch) each one coupled to a 8×8
multianode position sensitive photomultiplier Hamamatsu H8500. The
signal readout is performed by a custom front-end electronics con-
nected to a FPGA, which embeds a coincidence processor with a time
window of 3 ns [19]. The distance between the two heads was set to
48 cm. A more detailed description of the system can be found in
[20,21].
2.2. Phantom irradiation
In this study 3 diﬀerent phantoms were irradiated. Two of them are
a homogeneous slab of PMMA and of brain equivalent tissue (herein-
after referred to as BRAIN) with a transverse section of 5×5 cm2 and a
length of 14 cm along the beam direction. The other test object, named
ZEBRA, is made up of 4 slices of PMMA and 2 of BRAIN alternated
along the beam axis (see Fig. 1). All the phantoms are inserted in a
PMMA holder bringing to a ﬁnal phantom dimension of 8 × 8 × 14 cm3.
Density and chemical composition of PMMA and BRAIN are reported
in Table 1. All the phantoms were irradiated with a 130 MeV pencil
beam with a gaussian transversal proﬁle (FWHM≃10 mm).
Irradiations where performed with high (1010 protons) and low (109
protons) statistics, corresponding respectively to an entrance dose of
800 cGy and 80 cGy and delivery times of 14 s and 2 s.
2.3. Data processing
PET data are acquired in form of photon pairs detected in a
coincidence time window of 3 ns within the energy window
[350, 850] keV. Each pair deﬁnes a line-of-response (LOR), and it is
stored in a ﬁle containing the number of hit detected for each LOR. To
obtain the 3-D activity image these data ﬁrst undergo to a normal-
ization procedure, based on an ﬂat-ﬁeld acquisition of a homogeneous
planar phantom ﬁlled with 18FDG [22], and subsequently are processed
using a Maximum-Likelihood-Expectation-Maximization algorithm
[23] which makes use of an analytical model of the system matrix.
The reconstructed ﬁeld of view (FOV) has a volume of 10×16×16 cm3,
segmented into 1 mm3 voxels. Images can be extracted in diﬀerent
planes: an example of a sagittal plane view is shown in Fig. 2.
When only elemental analysis is required, the reconstruction
process is not needed and the raw data, expressed as coincidence rate
as a function of time, acquired over the whole FOV can be used. In this
case a random coincidences subtraction process, based on the delayed
window technique, is applied [24]. For each irradiation data were
acquired for 550 s after the beam is turned oﬀ (beam-oﬀ period).
2.4. Data analysis
For all the experiments presented in our study data analysis has a
dual purpose: the proﬁle analysis is aimed to extract information about
the location of the activated material within the phantom while the
elemental analysis highlights composition diﬀerences among the
phantoms.
2.4.1. Proﬁle analysis
Images are reconstructed using data collected within 120 s after the
end of the irradiation: 1-D activity proﬁles are obtained projecting all
the events included in an elliptical ROI in the transverse plane on the z
axis, that represents the beam axis (see also [18]). This procedure is
suggested by the geometrical conﬁguration of DoPET which, as
discussed in Section 2.1, is based on two planar heads. Such conﬁg-
uration makes the beam axis a privileged direction, i.e., the direction
with the maximal spatial resolution corresponding to 1.5 mm [25].
This kind of analysis allows us to recover spatial information on the
activation and, from the temporal point of view, it provides an
integrated information.
2.4.2. Elemental analysis
Elemental analysis is carried out using the data collected during the
whole acquisition time of 550 s. Since the recorded activity is due to β+
radioactive decays, the decrease in the coincidence rate after the
irradiation is a sum of exponential decays, a diﬀerent one for each











where t is the time elapsed from the end of the irradiation, ai is a free
parameter and Ti is the half-life of each isotope.
Once the ﬁt has been performed the percent contribution of a given
isotope to the overall signal (Ci) in a given time window [t , t ]1 2 is
computed as:
Fig. 1. 3D view of ZEBRA phantom: light blue slabs are PMMA, brown slabs are BRAIN.
(For interpretation of the references to color in this ﬁgure legend, the reader is referred to
the web version of this article.)
Table 1
Density and chemical composition (fraction by weight) of the used materials.
Material ρ (gcm−3) H (%) C (%) O (%) N (%)
PMMA 1.18 8.06 59.98 31.96 –
BRAIN 1.05 10.83 72.54 14.56 1.69
Fig. 2. ZEBRA phantom irradiation: image of the activated volume in the sagittal plane.



























where t1 refers to the beginning of the beam-oﬀ period and
t = t + 550 s2 1 . The error associated to each contribution derives from
the uncertainty of the estimated parameters ai, propagated using the
standard error propagation rules.
According to the chemical composition of our phantoms, the most
relevant expected β+ emitters, along with their reaction channels, are
summarized in Table 2.
This kind of analysis allows us to recover time information at the
expenses of spatial information: in fact, the whole FOV is considered,
i.e., the signal is spatially integrated.
3. Results and discussion
3.1. Activity proﬁles
In Fig. 3 the activity proﬁles along z-axis of the three phantoms
obtained with high statistics (i.e., 1010 protons) are reported. All the
shown proﬁles represent the reconstructed statistics and the ampli-
tudes are strictly related to the number of impinging protons. It is clear
that while the proﬁles of homogeneous phantoms (square markers for
PMMA and triangle markers for BRAIN) are quite uniform, the proﬁle
of the ZEBRA phantom (ﬁlled area) presents two activity deﬁcits each
about 20 mm wide. The location of these details, respectively at 20 and
60 mm from the phantom entrance, coincides with the actual location
of the BRAIN slabs. From the proﬁle reported in Fig. 4 the width of the
BRAIN slabs are estimated by ﬁtting the edges of the activity defects
with an error function. If we compute the diﬀerence between the 50%
of the proﬁle rise and fall, the resulting widths are 20.4 ± 0.5 mm for
the ﬁrst slab and 19.7 ± 0.6 mm for the second one. These values are
well compatible with the actual width (20 mm) of the BRAIN slabs.
Furthermore, the amplitude of the ZEBRA proﬁle corresponds to that
of homogeneous PMMA proﬁle where PMMA slabs are located and to
the homogeneous BRAIN proﬁle where BRAIN slabs are present. So,
comparing the ZEBRA proﬁle with the homogeneous ones, we have
both a spatial and composition information along the beam axis.
Moreover, as it should be expected, the activity fall-oﬀ edges of the
three phantoms depend on the phantom density: the less dense
phantom (BRAIN) has a deeper activity fall-oﬀ.
The lower activity signal of BRAIN with respect to PMMA is mainly
due to the lower percentage of oxygen (see Table 1) together with the
chosen time window. In fact, if we reconstruct the activity distribution
of the ZEBRA phantom integrating the signal at later times, from 300
to 550 s after the end of the irradiation, we obtain the proﬁle reported
in Fig. 5: in this case the oxygen signal is almost lost and the BRAIN
slabs cannot be distinguished from the PMMA.
The previous results are encouraging but they are obtained using a
high statistic pencil beam. To move to pencil beams that are more
commonly encountered in clinical practice when hypofractionation
Table 2
Relevant reaction channels [7,26]. Energies labelled with * are calculated in the
laboratory reference frame using relativistic conservation of energy-momentum and
imposing the threshold condition, i.e., the products have null kinetic energy in the center
of mass reference frame.
Isotope Half-life (s) Channel Threshold (MeV)
11C 1220 12C(p,pn)11C 20.61
16O(p, 3p3n)11C 59.64
10C 19.3 12C(p,p2n)10C 35*
16O(p,3p4n)10C 72*
15O 122.2 16O(p,pn)15O 16.79
8B 0.770 12C(p,2p3n)8B 61*
Fig. 3. Activity proﬁles of PMMA, ZEBRA and BRAIN phantoms irradiated with 1010
protons: the z coordinate corresponds to the beam axis. Square points refers to PMMA,
triangles to BRAIN and grey area to ZEBRA phantom. Proﬁles are obtained integrating
the signal in the (0, 120 s) time window.
Fig. 4. Activity proﬁles of ZEBRA phantom obtained with 1010 protons: the edges of the
activity deﬁcits corresponding to the presence of BRAIN slabs are ﬁtted with error
functions (red). (For interpretation of the references to color in this ﬁgure legend, the
reader is referred to the web version of this article.)
Fig. 5. Activity proﬁles of ZEBRA phantoms obtained with 1010 protons: the edges of the
activity deﬁcits corresponding to the presence of BRAIN slabs are ﬁtted with error
functions. Proﬁle is obtained integrating the signal in the [300,550] s time window.
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4schemes are applied, the ZEBRA phantom was irradiated also with a
beam containing 109 protons: the resulting proﬁle is reported in Fig. 6.
As we should expect the proﬁle intensity is one order of magnitude
lower than the high statistics irradiation. In this case the proﬁle is
dominated by noise and, even if the presence of two activity defects can
be observed, neither the exact location nor the dimension of this
cavities can be unambiguously deduced.
3.2. Temporal proﬁles
In Fig. 7(a)–(c), the coincidence rate as a function of time recorded
during the beam-oﬀ period of the high statistics irradiation are shown.
These data are ﬁtted with the function reported in Eq. (2) including all
the 4 isotopes listed in Table 2. As it is clear from the ﬁgures, the best
ﬁt function includes the contributions of 11C, 15O, 10C, 8B where, as
expected, the ﬁst two isotopes are the most abundant ones. The
presence of these 4 isotopes is also reported in other experiments
where 55 MeV protons impinging on a PMMA phantom and an ad-hoc
experimental setup for time analysis are used [27]. From Fig. 8, which
displays only the ﬁrst 270 s after the irradiation, it can be inferred that
moving from PMMA (top) to BRAIN phantom (bottom) the contribu-
tion of 15O reduces by a factor 2 while 11C slightly increases: this
behavior reﬂects the diﬀerent composition of the two phantoms.
Quantitative considerations can be drawn observing Fig. 9, where only
the percent contribution of 11C and 15O are considered since they
constitute more than 90% of the recorded signal. In the graph we can
see that the contribution of 15O and 11C of the ZEBRA phantom are
intermediate between the PMMA and BRAIN phantoms. Furthermore,
for each phantom pair, the percent diﬀerences are statistically sig-
niﬁcant, i.e., they exceed 3 standard deviations. The same analysis is
repeated for the low statistics irradiation of the ZEBRA phantom (also
Fig. 6. Activity proﬁles of ZEBRA phantom obtained with 109 protons in the 0,120] s
time window: it is not possible to clearly identify the presence of BRAIN slabs.
Fig. 7. Recorded coincidence rate as a function of time for all the irradiations. Red line represents the ﬁt function, other lines correspond to each isotopic contribution. Error bars are
visible only in (d) for long times, in the other cases they are smaller than points. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web
version of this article.)
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5reported in Fig. 7(d)). In this case, even if the statistics is reduced by a
factor 10, the percent contributions are still compatible with the high
statistics irradiations and signiﬁcantly diﬀerent from those of BRAIN
and PMMA phantoms. Thus, within the reported experimental condi-
tions, elemental analysis can provide useful information of the
phantom composition also with a lower proton statistics with respect
to proﬁle analysis. For the sake of completeness, Table 3 reports the
isotope percentages found in each irradiation.
4. Conclusions
This study investigated the capability of a PET monitoring proto-
type, i.e., DoPET, in discriminating diﬀerent irradiated material both in
space and time domains, with the aim to bring useful indications for
the monitoring practice in proton therapy.
The comparison between the proﬁle obtained integrating the signal
in a time window starting right after the irradiation [0,120] s and that
at later times [300,550] s, shows that the capability to acquire the 15O
signal is relevant not only for statistical reasons but is also crucial to
correctly discriminate the materials. So monitoring systems located
strictly close to the irradiated patient, i.e, in-beam systems, are
advantageous. The 1-D activity proﬁles analysis revealed that, irradiat-
ing with a high dose pencil beam a PMMA phantom where 2 slabs of
brain equivalent tissue are inserted, the system is capable of detecting
the presence of materials that diﬀer in oxygen composition, moving
from about 15–32%, allowing a correct estimate of the slab widths. The
imaging capabilities are reduced when the dose is lowered by a factor
10 since the proﬁle noise becomes predominant not allowing a clear
detection of the inserted slabs. This is a clear indication that more than
a direct imaging of the activated volume, as the PET signal is generated
from low statistics processes, a comparison between expected and
measured activity is advised. So the use of a Monte Carlo simulation
codes able to calculate the expected activity distribution is mandatory.
Along with 1-D activity distribution analysis, another approach to
retrieve elemental composition information was investigated. In fact,
studying the recorded coincidence rate as a function of time the
production of 4 β+ emitters (i.e., 11C, 15O, 10C, 8B) was evidentiated.
Considering only the most abundant isotopes, namely 11C and 15O, it
was shown that their percentage varies accordingly to the phantom
composition, i.e., they provide information on the phantom. The results
obtained analyzing the low dose irradiation are consistent with the high
dose data, hence the elemental analysis is found to be less dependent
on the proton statistics with respect to the proﬁle analysis. Here we
remark that, in the context of treatment monitoring, also these data,
which are obtained from a direct measurement of the irradiated object,
can be compared with Monte Carlo predictions to access whether the
treatment was correctly delivered or not.
On the other hand, the capability to detect speciﬁc isotopes can be
useful. In particular, being able to detect short-lived isotopes (e.g., 37K
and 38K) produced irradiating tissues containing calcium, it would be
possible to state if the irradiation of a bone structure took place: this
signature is relevant for cases in which the bone structure is adjacent to
the target volume but has to be avoided from irradiation.
Future developments of the presented analysis require, ﬁrst of all,
the development of new electronics to cope with the need to detect
short-lived isotopes. Then, a more in-depth study using anthropo-
morphic phantoms will be performed to investigate whether the
comparison with Monte Carlo predictions together with isotopic
analysis, allows to reduce the margins for range uncertainties currently
used in the deﬁnition of the target volume. This technique could be ﬁrst
tested in clinical practice in the context of hypofractionation schemes,
selecting speciﬁc pencil beams from the treatment plan.
Fig. 8. Zoom view for the coincidence rate in [0,270] s time window. Top: PMMA
homogeneous phantom. Central: ZEBRA phantom. Bottom: BRAIN homogeous phan-
tom.
Fig. 9. Percentages of 15O and 11C for all the studied irradiations.
Table 3
Percent isotopic contribution to the overall signal within 550 s from the irradiation end.
phantom type 11C (%) 15O (%) 10C (%) 8B (%) TOT (%)
PMMA 39.75 ± 0.29 52.19 ± 0.37 7.80 ± 0.14 0.26 ± 0.02 100
BRAIN 58.71 ± 0.37 20.41 ± 0.42 11.57 ± 0.17 0.31 ± 0.03 100
ZEBRA 1010 47.32 ± 0.32 43.70 ± 0.39 8.59 ± 0.16 0.39 ± 0.20 100
ZEBRA 109 47.82 ± 1.65 42.14 ± 1.79 9.56 ± 0.61 0.48 ± 0.07 100
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